It's not always easy for a young company to build enough momentum to launch three commercial products in less than a decade of existence but that's exactly what Veracyte Inc. is on track to do by the end of this year. The molecular diagnostics company based in South San Francisco, Calif. just secured a financing agreement with Visium Healthcare Partners that provides up to $45 million through a term loan and securities purchase option.

Last week, Endeavour Vision SA from Geneva, Switzerland announced it had closed the largest venture capital fund ever to be dedicated exclusively to medical technologies. Medtech Growth Limited Partners holds €250 million ($279 million) to be focused on late-stage medical device start-ups, and more specifically, those with a digital health component in their products.